Pharmacoeconomics of long-term treatment of rheumatoid arthritis

Author： Tugwell Peter   Blumenauer Barbara   Coyle Douglas  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.4, 2002-04, pp. : 417-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Experience with Etanercept in the Treatment of Rheumatoid Arthritis in Elderly and Younger Patients: Patient-Reported Outcomes from Multiple Controlled and Open-Label Extension Studies

By Schiff Michael H.  

Drugs & Aging, Vol. 23, Iss. 2, 2006-01 ,pp. : 167-178

Adis International

Access to resources Recommend Favorite

Long-term Etanercept Therapy Favors Weight Gain and Ameliorates Cachexia in Rheumatoid Arthritis Patients: Roles of Gut Hormones and Leptin

By  

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1956-1964

Bentham Science Publishers

Access to resources Recommend Favorite

Leflunomide for the treatment of rheumatoid arthritis

By Miceli-Richard Corinne   Dougados Maxime  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

Targeted treatment for rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1424, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Tetracyclines for the treatment of rheumatoid arthritis

By Alarcón G.S.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. : 1491-1498

Informa Healthcare

Access to resources Recommend Favorite